|
Market Closed -
Other stock markets
|
After hours 05:02:41 am | |||
| 762.73 USD | -2.84% |
|
763.80 | +0.14% |
| 21/06 | S&P 500 Edges Down Weekly as Declines Led by Health Care Outweigh Energy-Led Gains | MT |
| 21/06 | Sector Update: Health Care Stocks Retreat Late Afternoon | MT |
| Capitalization | 70TCr 61TCr 58TCr 52TCr 97TCr 61,00100Cr 1,09300Cr 6,80100Cr 2,60800Cr 27,94000Cr 2,64400Cr 2,58800Cr 1,02,93100Cr | P/E ratio 2025 * |
36x | P/E ratio 2026 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise value | 73TCr 63TCr 60TCr 54TCr 1,00200Cr 63,14600Cr 1,13100Cr 7,04000Cr 2,70000Cr 28,92200Cr 2,73700Cr 2,67900Cr 1,06,55200Cr | EV / Sales 2025 * |
12.2x | EV / Sales 2026 * | 10x |
| Free-Float |
99.81% | Yield 2025 * |
0.79% | Yield 2026 * | 0.88% |
More valuation ratios
* Estimated data
More news
Last Transcript: Eli Lilly and Company
More recommendations
More press releases
More news
| 1 day | +0.30% | ||
| 1 week | -6.07% | ||
| Current month | +3.40% | ||
| 1 month | +1.01% | ||
| 3 months | -8.87% | ||
| 6 months | +0.69% | ||
| Current year | -1.20% |
| 1 week | 755.56 |  | 825 |
| 1 month | 709 | | 825 |
| Current year | 677.09 | | 935.62 |
| 1 year | 677.09 | | 972.53 |
| 3 years | 290.31 | | 972.53 |
| 5 years | 129.21 | | 972.53 |
| 10 years | 64.18 | | 972.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 57 | 01/01/2017 |
Ruth Gimeno
PSD | President | - | - |
Lucas Montarce
DFI | Director of Finance/CFO | 48 | 09/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 64 | 01/01/2005 |
Ralph Alvarez
BRD | Director/Board Member | 69 | 01/04/2009 |
| Director/Board Member | 53 | 12/12/2011 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 6.49% | 21 M€ | +0.15% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.84% | -6.07% | -14.44% | +162.20% | 70TCr | ||
| -0.62% | -4.39% | +2.84% | -11.61% | 36TCr | ||
| -2.58% | -8.36% | -51.66% | +27.37% | 33TCr | ||
| -0.10% | -3.70% | +8.13% | +34.00% | 33TCr | ||
| -0.27% | -4.88% | +3.80% | -14.52% | 25TCr | ||
| -0.34% | -3.24% | +1.03% | +20.14% | 23TCr | ||
| -1.52% | -5.78% | -15.79% | +4.72% | 22TCr | ||
| -0.29% | -3.37% | -38.23% | -6.57% | 20TCr | ||
| -0.10% | -2.68% | -5.44% | +23.27% | 16TCr | ||
| +0.38% | -3.50% | -12.55% | -48.48% | 14TCr | ||
| Average | -0.15% | -3.13% | -12.23% | +19.05% | 29.21TCr | |
| Weighted average by Cap. | -0.08% | -3.30% | -12.37% | +43.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.96TCr 5.17TCr 4.87TCr 4.43TCr 8.18TCr 5,15600Cr 9.24TCr 57TCr 22TCr 2,36200Cr 22TCr 22TCr 8,70000Cr | 7.14TCr 6.2TCr 5.84TCr 5.31TCr 9.81TCr 6,18200Cr 11TCr 69TCr 26TCr 2,83100Cr 27TCr 26TCr 10,43100Cr |
| Net income | 1.91TCr 1.66TCr 1.56TCr 1.42TCr 2.62TCr 1,65400Cr 2.96TCr 18TCr 7.07TCr 76TCr 7.17TCr 7.01TCr 2,79000Cr | 2.52TCr 2.19TCr 2.06TCr 1.87TCr 3.46TCr 2,18100Cr 3.91TCr 24TCr 9.32TCr 1LCr 9.45TCr 9.25TCr 3,67900Cr |
| Net Debt | 2.48TCr 2.15TCr 2.03TCr 1.84TCr 3.4TCr 2,14500Cr 3.84TCr 24TCr 9.17TCr 98TCr 9.3TCr 9.1TCr 3,62000Cr | 1.22TCr 1.06TCr 996.45Cr 906.37Cr 1.67TCr 1,05500Cr 1.89TCr 12TCr 4.51TCr 48TCr 4.57TCr 4.47TCr 1,78000Cr |
More financial data
* Estimated data
Employees
47,000
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/25/20 | 762.73 $ | -2.84% | 61,08,451 |
| 18/25/18 | 785.03 $ | -0.78% | 24,42,938 |
| 17/25/17 | 791.24 $ | -2.02% | 28,75,634 |
| 16/25/16 | 807.58 $ | -1.44% | 28,21,770 |
| 13/25/13 | 819.36 $ | +0.90% | 27,54,603 |
Delayed Quote Nyse, June 21, 2025 at 01:30 am IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
762.73USD
Average target price
951.98USD
Spread / Average Target
+24.81%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition